Biotage AB (OSTO:BIOT)
kr 152.3 0.5 (0.33%) Market Cap: 12.19 Bil Enterprise Value: 12.07 Bil PE Ratio: 46.16 PB Ratio: 3.20 GF Score: 97/100

Q4 2023 Biotage AB Earnings Call Transcript

Feb 15, 2024 / 02:00PM GMT
Release Date Price: kr169.9 (+13.65%)
Torben JÃ;rgensen
Biotage AB - CEO and President

¶ -

Well, welcome to this webinar where we are going to present our Q4 results and also a little bit on the full year. And as you know, there is the disclaimer, [Vas] and I don't want to say any more of that. What I want to like to start with is a little bit on what we are trying to simplify the message, what kind of company. We are and we are redefining that we are the global go to separations company to make it more simple and utilizing all of the modalities that we now have in our portfolio going from small molecules to biologics.

It makes it's much, much clearer seen from our point of view to put the measures from right out to people like yourself and also to our employees and to our stakeholders in general terms and saying that I just want to say it has been a fantastic time to come back.

Some of you know that I have been here before and are now just for the time being getting in CEO, and going to more of the executive summary before I lead the word to Andrew candidates less as you have also seen is now a permanent CFO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot